期刊文献+

人血管内皮生长因子_(165)与嵌合水蛭肽融合基因防治兔颈动脉损伤后再狭窄的实验研究 被引量:1

Effects of fusion gene encoding the hVEGF_(165) and fused hirudin on restenosis of injured carotid artery induced by angioplasty
原文传递
导出
摘要 目的观察人血管内皮生长因子165(hVEGF_(165))与嵌合水蛭肽融合基因(fusedhirudin,FH)对兔颈动脉损伤后再狭窄的防治作用,为再狭窄的基因治疗提供新的思路。方法通过基因重组构建 hVEGF_(165)与 FH 的融合基因(hVEGF_(165)-FH)。制备兔颈总动脉血管成形术损伤后再狭窄模型,损伤局部转染该融合基因作为治疗组。同时局部转染 pcDNA3.0空质粒作为对照组,通过血管造影、病理分析等观察融合基因是否抑制兔颈总动脉血管成形术后再狭窄。结果局部转染融合基因后1周和3周,造影显示治疗组血管狭窄程度与对照组比较显著减轻;病理分析显示。治疗组较对照组管腔狭窄程度显著减轻(1周:11.50% vs 33.25%;3周:19.75% vs 52.25%,P<0.05);治疗组较对照组内膜增生程度(内膜/中膜,I/M)显著减轻(1周:0.12 vs 0.50;3周:0.35 vs 1.07,P<0.05)。同时融合基因对血管损伤处的血栓形成有抑制作用,但对系统凝血指标无影响,无全身出血并发症。结论融合基因 hVEGF_(165)-FH 可有效地预防兔颈动脉成形术后再狭窄。以内皮修复为基础,构建双靶点甚至多靶点的融合基因可能是未来再狭窄防治的一个有效策略。 Objective To study the effects of fusion gene encoding the hVEGFI65 and fused hirudin on restenosis of injured carotid artery. Methods A fusion gene encoding hVEGF165 and fused hirudin (hVEGF165-FH) was constructed and clone into the eukaryotic expression vector pcDNA3.0, thus constructing the plasmid VEGF165-FH/pcDNA3. O. Its activities to stimulate endothelial cell proliferation and to inhibit thrombosis were identified. Sixteen New Zealand rabbits underwent ligation of external carotid artery and a balloon was inserted into the common carotid artery for 30 minutes so as to construct model of restenosis of injured carotid artery. Then the rabbits were randomly divided into 4 equal groups. In the oneweek and 3-week control groups, 400 p.g of DNA of the plasmid pcDNA3.0 were transfused into the arterial lumen at the injured part immediately after the angioplasty, and 400 p.g of DNA of the plasmid VEGF165-FH/ pcDNA3.0 were transfused in the 1-week and 3-week experimental groups. One week and 3 weeks after the treatment peripheral blood samples were collected to detect the activated partial thromboplastin time (APTT) , thrombin time (TT), and platelet aggregation rate, and then the rabbits underwent angiography to observe the situation of restenosis. Then the rabbits were killed to take out the injured part of artery to undergo pathological examination and Western blotting. Results The values of APTT,TT, and platelet aggregation rate were not significantly different among the 4 groups. Angiography conducted 1 and 3 weeks later showed that restenosis was significandy mild in the 2 experimental groups in comparison with the 2 control groups, and severe restenosis was seen in the 3-week control group. Western blotting showed that expression of specific fused protein could be found in the 1-week and 3-week experimental group, the amount of the latter group being less than that of the former group; however, no expression of specific fused protein was found in the 2 control groups. Pathological examination sh
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第38期2698-2702,共5页 National Medical Journal of China
基金 国家自然科学基金(30200281)
关键词 内皮生长因子 水蛭素 基因融合 基因疗法 Endothelial growth factors Hirudin Gene fusion Gene therapy
  • 相关文献

参考文献9

二级参考文献38

  • 1沈雳,陈少萍,蔡在龙,杨生生,秦永文.嵌合水蛭肽的构建与活性分析[J].中国生物化学与分子生物学报,2004,20(5):702-706. 被引量:4
  • 2[1]Schror K. Anti-integrins-new platelet function inhibitors for therapy and prevention of acute coronary syndrome. Wien Klin Wochenschr, 1999,111(3) :90 ~ 97 被引量:1
  • 3[4]Church F C. Phillips J E. Chimeric antithrombin peptide.Characterization of an Arg-Gly-Asp (RGD)- and hirudin acrboxl terminus-containing synthetic peptide. J Biol Chem, 1991,266(18):11975 ~ 11979 被引量:1
  • 4[5]Naski M C, Fenton J W 2nd, Maraganore J M, Olson S T, Shafer J A.The COOH- terminal domain of hirudin. An exosite- directed competitive inhibitor of the action of alpha-thrombin on fibrinogen. J Biol Chem, 1990, 265(23):13484~ 13489 被引量:1
  • 5[6]Theroux P. Inhibition of the platelet glycoprotein Ⅱ b/Ⅲ a receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.Platelet receptor inhibition in ischemic syndrome management in patients iimited by unstable signs and symptoms (PRISM- PLUS ) study investigators. N Engl J Med, 1998, 338(21): 1488 ~ 1497 被引量:1
  • 6[7]Eikelboom J, White H, Yusuf S. The evolving role of direct thrombin inhibitors in acute coronary syndromes. J Am Coll Cardiol, 2003, 41(4 Suppl S) :70S ~ 78S 被引量:1
  • 7[8]Hasan A A, Warnock M, Nieman M, Srikanth S, Mahdi F, Krishnan R, Tulinsky A, Schmaier A H. Mechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombin. Am J Physiol Heart Circ Physiol, 2003, 285(1):H183~193 被引量:1
  • 8[9]van Zyl W B, Pretorius G H, Hartmann M, Kotze H F. Production of a recombinant antithrombotic and fibrinolytic protein, PLATSAK, in Escherichia coil. Thromb Res, 1997, 88(5):419~426 被引量:1
  • 9[10]Wu T M, Li M L, Chou T C. Inhibitory effect of hexapeptide(RGRHGD) on platelet aggregation. Thromb Res ,2000,97(4): 191 ~199 被引量:1
  • 10Schwartz RS, Huber FKC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J AM Coll Cardiol, 1992, 19: 267 - 274 . 被引量:1

共引文献27

同被引文献20

引证文献1

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部